458-50-4

Basic information

• Product Name: 4-BROMO-3-FLUOROANISOLE
• Synonyms: 4-BROMO-3-FLUOROANISOLE 99+%;1-Bromo-2-fluoro-4-methoxybenzene;4-Bromo-3-fluoroanisole;4-Bromo-3-fluoroanisole 98%;1-Bromo-2-fluoro-4-methoxybenzene, 4-Bromo-3-fluorophenyl methyl ether;4- broMo-3- fluoroether;Benzene, 1-bromo-2-fluoro-4-methoxy-
• CAS NO: 458-50-4
• Molecular Formula: C₇H₆BrFO
• Molecular Weight: 205.02
• Product Categories: Anisole;Aromatics;Intermediates & Fine Chemicals;Pharmaceuticals
• Mol File: 458-50-4.mol
• Article Data: 16

Chemical Properties

• Melting Point: 217-219°C
• Boiling Point: 195.4 °C at 760 mmHg
• Flash Point: 85°(185°F)
• Appearance: /
• Density: 1.60
• Vapor Pressure: 0.59mmHg at 25°C
• Refractive Index: 1.5410-1.5450
• Storage Temp.: Keep in dark place,Sealed in dry,Room Temperature
• CAS DataBase Reference: 4-BROMO-3-FLUOROANISOLE(CAS DataBase Reference)
• NIST Chemistry Reference: 4-BROMO-3-FLUOROANISOLE(458-50-4)
• EPA Substance Registry System: 4-BROMO-3-FLUOROANISOLE(458-50-4)

Safety Data

• Hazard Codes: Xi
• Statements: 36/37/38
• Safety Statements: 23-26-37-60
• RIDADR: 1993
• HazardClass: IRRITANT
• PackingGroup: Ⅲ
• Hazardous Substances Data: 458-50-4(Hazardous Substances Data)

Usage

Chemical Properties

Clear colorless to light yellow liquid

Uses

4-Bromo-3-fluoroanisole is a halo-aryl compound used in the preparation of orally available mGlu1 receptor enhancers.

InChI:InChI=1/C7H6BrFO/c1-10-5-2-3-6(8)7(9)4-5/h2-4H,1H3

Upstream product

• 456-49-5 1-fluoro-3-methoxybenzene 
• 446-38-8 2-fluoro-4-methoxy-1-nitro-benzene 
• 394-42-3 2-fluoro-4-methoxy-benzoic acid 
• 121219-03-2 4-bromo-3-fluorophenol 
• 77-78-1 dimethyl sulfate 
• 348-57-2 2,4-difluorobromobenzene 
• 865-33-8 potassium methanolate 
• 67-56-1 methanol 
• 74-88-4 methyl iodide 
• 458-52-6 2-fluoro-4-(methoxy)aniline 

Downstream Products

• 1160653-94-0 3-bromo-2-fluoro-6-methoxybenzaldehyde 
• 1022154-92-2 2,2-difluoro-1-(2-fluoro-4-methoxyphenyl)ethanone 
• 1374134-33-4 methyl 3-(2-fluoro-4-methoxyphenyl)-3-hydroxycyclobutanecarboxylate 
• 944317-83-3 methyl 2'-fluoro-4'-methoxy-2-methyl-5'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)biphenyl-4-carboxylate 
• 1374132-22-5 methyl 5'-[4-({(4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-4-methyl-2-oxo-1,3-oxazolidin-3-yl}methyl)2-(3-fluoroazetidin-1-yl)pyrimidin-5-yl]-2'-fluoro-4'-methoxy-2-methylbiphenyl-4-carboxylate 
• 1374132-48-5 5'-[4-({(4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-4-methyl-2-oxo-1,3-oxazolidin-3-yl}methyl)2-(3-fluoroazetidin-1-yl)pyrimidin-5-yl]-2'-fluoro-4'-methoxy-2-methylbiphenyl-4-carboxylic acid 
• 16817-46-2 1-(2-fluoro-4-methoxyphenyl)acetone 
• 335125-98-9 2,3',4',5'-tetrafluoro-[1,1'-biphenyl]-4-ol 
• 1217340-23-2 3-(4-fluoro-2-(4-fluorophenyl)-3-(methylcarbamoyl)benzofuran-5-yl)-4-methylbenzoic acid 
• 1217338-97-0 4-fluoro-2-(4-fluorophenyl)-N-methyl-5-(2-methyl-5-(1-(pyrimidin-2-yl)cyclopropylcarbamoyl)phenyl)benzofuran-3-carboxamide 

Relevant articles and documents

Design of an Electron-Withdrawing Benzonitrile Ligand for Ni-Catalyzed Cross-Coupling Involving Tertiary Nucleophiles

The design of new ligands for cross-coupling is essential for developing new catalytic reactions that access valuable products such as pharmaceuticals. In this report, we exploit the reactivity of nitrile-containing additives in Ni catalysis to design a benzonitrile-containing ligand for cross-coupling involving tertiary nucleophiles. Kinetic and Hammett studies are used to elucidate the role of the optimized ligand, which demonstrate that the benzonitrile moiety acts as an electron-acceptor to promote reductive elimination over β-hydride elimination and stabilize low-valent Ni. With these conditions, a protocol for decyanation-metalation and Ni-catalyzed arylation is conducted, enabling access to quaternary α-arylnitriles from disubstituted malononitriles.

Fast and Tight Boronate Formation for Click Bioorthogonal Conjugation

A new click bioorthogonal reaction system was devised to enable the fast ligation (kON≈340 m-1 s-1) of conjugatable derivatives of a rigid cyclic diol (nopoldiol) and a carefully optimized boronic acid partner, 2-methyl-5-carboxymethylphenylboronic acid. Using NMR and fluorescence spectroscopy studies, the corresponding boronates were found to form reversibly within minutes at low micromolar concentration in water, providing submicromolar equilibrium constant (Keq≈105-106 m-1). Efficient protein conjugation under physiological conditions was demonstrated with model proteins thioredoxin and albumin, and characterized by mass spectrometry and gel electrophoresis.

ISOTHIAZOLE DERIVATIVES AS GPR120 AGONISTS FOR THE TREATMENT OF TYPE II DIABETES

Disclosed are compounds, compositions and methods for treating of disorders that are affected by the modulation of the GPR120 receptor. Such compounds are represented by Formula (I) as follows: wherein R1, G, and Q are defined herein.